Delivery Order SPE2DB24D2217-SPE2DB25FJXPY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,099.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,431.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of DLA's pharmaceutical procurement operations. The contract's place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $20,941.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units). The contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,468.68 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,957.32 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count units) on August 10, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,309.59 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,305.23 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (30-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-set-aside competitively awarded contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $7,851.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 29, 2025, with completion required by July 30, 2025. This firm fixed-price, non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement to...
- The Defense Logistics Agency awarded a delivery order valued at $32,361.49 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,128.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity. Issued on July 18, 2025, with an ultimate completion date of July 21, 2025, this firm fixed-price contract represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DB24D2217Indefinite Delivery Contract
- SPE2DB24D2217-SPE2DB25FJXPYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,991.34 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count). The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, utilizing firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, serving military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order represents a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/20/25 |